Fluorescence Immunoassay (FIA)
Chemiluminescence Immunoassay (CLIA)
Rapid Test (Colloidal gold)
Quality Control
Chest Pain Center
Stroke Center
Trauma Center
Critical Maternal Care Center
Critical Children and Neonatal Care Center
Center for Reproductive Medicine
Hierarchical diagnosis and treatment
Hospital-wide solution
May 15,2020
WESAIL Novel Coronavirus Detection Reagent Obtain CE Certificate
On May 15, 2020, the new coronavirus (COVID-19) IgM /IgG test kit developed and produced by Guangdong Weishi Biotechnology Co., Ltd. was awarded CE certification. As a safety certification mark, "CE" is regarded as a passport for manufacturers to open the European market. Getting CE certification means that the new coronavirus kit produced by Weishi can be sold in the European Union and other countries that recognize CE certification. This kit is suitable for the rapid detection of IgM/IgG antibody of novel coronavirus in human serum, plasma and whole blood.
Jun 17,2020
WESAIL Novel Coronavirus Detection Reagent Enters the White List of Epidemic Prevention Materials Export of the Ministry of Commerce
On June 17, 2020, the new coronavirus (COVID-19) IgM /IgG test kit developed and produced by Guangdong Weishi Biotechnology Co. As the testing reagents have obtained the EU CE certification, in accordance with the latest announcement requirements, only a written statement is submitted, promising that the products meet the quality standards and safety requirements of the customer's country, you can export the relevant epidemic prevention materials. The simplification of export procedures will facilitate the foreign sales of this new crown testing reagent and help the global war epidemic.
Oct 16,2020
WESAIL New Crown Antigen Test Products and Antibody JIU Kits have been awarded CE Certificate by CIBG in the Netherlands
On September 28, 2020, the company's self-developed and produced new crown antigen test products and antibody JIU kits have obtained CE certificates issued by CIBG in the Netherlands, which means that the company's two products can be sold in the European Union and other recognized CE-certified markets.
Oct 27,2020
WESAIL Appears at 2020 China (Dongguan) International Medical Epidemic Prevention and Big Health Industry Development Forum and Exhibition
From October 19 to 20, 2020, Guangdong Weishi Biotechnology Co., Ltd. participated in the "2020 Dongguan International Medical Epidemic Prevention and Great Health Exhibition"
Feb 05,2021
WESAIL Influenza Novel Coronavirus Antigen Joint Inspection Kit Enters White List of Ministry of Commerce
On January 5, 2021, the novel influenza coronavirus detection kit developed and produced by Guangdong Weishi Biotechnology Co., Ltd. has passed the expert review organized by the China Chamber of Commerce for Import and Export of Medicines and Health Products
WESAIL products pass German PEI performance verification
The new coronavirus antigen detection kit developed and produced by WESAIL has passed the performance verification of the Paul Ehrlich Institute in Germany.
Feb 18,2021
WESAIL new crown series products have been approved by Germany, Russia, Turkey, France
New Crown Neutralizing Antibody Obtain CE Certificate
Mar 30,2021
WESAIL debuts at CACLP to make POCT easier, faster and more accurate
Guangdong Weishi Biotechnology Co., Ltd. (hereinafter referred to as "WESAIL") and its star products independently developed and produced by the company were invited to participate in the flagship expo event of in vitro diagnosis industry -- CACLP.
Apr 13,2021
WESAIL New Crown Neutralizing Antibody Test Kit (Latex Enhanced Immune Transmittance Turbidimetry) and Handheld Colloidal Gold Immune Analyzer Won CE Certificate
WESAIL's self-developed and produced novel coronavirus (COVID-19) neutralizing antibody detection kit (latex-enhanced immune transmission turbidimetry) and handheld colloidal gold immune analyzer have won EU CE certification.